Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Váradi A, Kói T, Lang Z, Ács N, Kopa Z, Hegyi P, Hadaschik B, Grünwald V, Nyirády P, Szarvas T. Fazekas T, et al. Among authors: nyirady p. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):665-672. doi: 10.1038/s41391-022-00626-2. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509931 Free PMC article. Review.
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Tschirdewahn S, et al. Among authors: nyirady p. Urol Oncol. 2014 Jul;32(5):663-9. doi: 10.1016/j.urolonc.2014.02.004. Epub 2014 May 9. Urol Oncol. 2014. PMID: 24814404
Current State of ERG as Biomarker in Prostatic Adenocarcinoma.
Acs B, Szarvas T, Szekely N, Nyirady P, Szasz AM. Acs B, et al. Among authors: nyirady p. Curr Cancer Drug Targets. 2015;15(8):643-51. doi: 10.2174/156800961508151001100829. Curr Cancer Drug Targets. 2015. PMID: 26452381 Review.
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
Vom Dorp F, Tschirdewahn S, Niedworok C, Reis H, Krause H, Kempkensteffen C, Busch J, Kramer G, Shariat SF, Nyirady P, Rübben H, Szarvas T. Vom Dorp F, et al. Among authors: nyirady p. J Urol. 2016 Apr;195(4 Pt 1):1120-5. doi: 10.1016/j.juro.2015.09.084. Epub 2015 Oct 8. J Urol. 2016. PMID: 26454102
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Módos O, Reis H, Niedworok C, Rübben H, Szendröi A, Szász MA, Tímár J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, Hollósi P, Nyirády P, Szarvas T. Módos O, et al. Among authors: nyirady p. Oncotarget. 2016 Jun 28;7(26):39293-39301. doi: 10.18632/oncotarget.9828. Oncotarget. 2016. PMID: 27283768 Free PMC article.
Why are upper tract urothelial carcinoma two different diseases?
Szarvas T, Módos O, Horváth A, Nyirády P. Szarvas T, et al. Among authors: nyirady p. Transl Androl Urol. 2016 Oct;5(5):636-647. doi: 10.21037/tau.2016.03.23. Transl Androl Urol. 2016. PMID: 27785420 Free PMC article. Review.
180 results